Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Bladder Cancer Clinical Trials
Bladder Cancer clinical trials are recruiting across 202 cities. Here are the cities with the most active studies:
Bladder Cancer Trial Phases
64 research organizations are sponsoring bladder cancer trials.
About Bladder Cancer
Bladder cancer occurs in the tissues of the bladder and is one of the most common cancers. It has a high recurrence rate, requiring ongoing monitoring. Treatments include surgery, intravesical therapy, chemotherapy, and immunotherapy.
Clinical trials are advancing new treatments for bladder cancer. Currently, 100 studies are recruiting a combined 120,558 participants across the United States. Research is being conducted by 64 organizations including M.D. Anderson Cancer Center, National Cancer Institute (NCI), Photocure and 61 others.
2026 Bladder Cancer Research Landscape
As of October 2026, the bladder cancer clinical trial landscape includes 100 actively recruiting studies across 202 cities in the United States. These studies are collectively seeking 120,558 participants, with an average enrollment target of 1,206 per study.
The research spans multiple phases of development: 32 studies are in PHASE2, 24 studies are in PHASE3, 11 studies are in NA, 10 studies are in PHASE1, 1 study is in EARLY_PHASE1, 1 study is in PHASE4. The presence of Phase 3 trials indicates that some bladder cancer treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 64 different organizations, including M.D. Anderson Cancer Center, National Cancer Institute (NCI), Photocure, Tampere University Hospital, Convergent Genomics, Inc., and 59 others. The large number of sponsors reflects significant research interest and investment in bladder cancer treatment advancement.
Geographically, bladder cancer trials are most concentrated in Los Angeles, California (22 trials); Little Rock, Arkansas (15 trials); Chicago, Illinois (13 trials); Orange, California (13 trials); Washington D.C., District of Columbia (12 trials) and 7 other cities.
Featured Bladder Cancer Studies
Highlighted recruiting studies for bladder cancer, selected by enrollment size and research scope.
Prospective Collection And Molecular Analysis Of Biospecimens And Clinical Data From Patients With Urothelial Carcinoma And Related Malignancies Of The Urinary Tract
To collect, process, store, and study biological samples and related clinical and imaging data from participants with known or suspected urothelial carcinoma or another related malignancy of the urinary tract.
The Vanguard Study: Testing a New Way to Screen for Cancer
The Vanguard Study is a feasibility study to explore several aspects of evaluating multi-cancer detection (MCD) tests in a future definitive randomized controlled trial. An MCD test measures markers in the blood in order to screen for multiple cancers simultaneously. There is a need to understand how MCDs may work as cancer screening tools. The goal of cancer screening is to reduce the burden of c...
Blue Light Cystoscopy With Cysview® Registry
Registry study to gather more information on the current use of Blue Light Cystoscopy with Cysview (BLCC) in urologists' practices.
Frequently Asked Questions About Bladder Cancer Clinical Trials
Are there bladder cancer clinical trials near me?
Yes, there are 100 bladder cancer clinical trials currently recruiting across 202+ cities in the United States, including Los Angeles, California; Little Rock, Arkansas; Chicago, Illinois. Browse the studies above to find one at a location convenient for you.
How do I join a bladder cancer clinical trial?
To join a bladder cancer clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are bladder cancer clinical trials free?
Yes, participation in bladder cancer clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of bladder cancer treatments are being studied?
Current bladder cancer clinical trials are testing a range of approaches across PHASE2 (32 studies), PHASE3 (24 studies), NA (11 studies), PHASE1 (10 studies), EARLY_PHASE1 (1 study), PHASE4 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 64 research organizations.
Is it safe to participate in bladder cancer clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated October 18, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated October 18, 2026 · Data from ClinicalTrials.gov